Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline plus speech pathology for vocal cord dysfunction
ACTRN12619000158167Phase 3Completed
- Sponsor
- La Trobe University
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vocal cord dysfunction (VCD) comparing Amitriptyline + speech pathology with Placebo + speech pathology (2 arms). Primary endpoint: Vocal cord dysfunction symptoms. Started Jan 2020; status: completed.
02
Drugs
amitriptyline
03
Conditions
vocal cord dysfunction (VCD)
Beyond the preview
Go deeper on ACTRN12619000158167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000158167.